Back to Search
Start Over
PL02.03 Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial.
- Source :
- Journal of Thoracic Oncology; 2021 Supplement, Vol. 16 Issue 10, pS844-S845, 2p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 16
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 153096917
- Full Text :
- https://doi.org/10.1016/j.jtho.2021.08.030